An update on dietary therapies in paediatric Crohn's disease
Results of a literature update on original articles published from May 2022–November 2023, in the dietary management of pediatric Crohn's disease.
Results of a literature update on original articles published from May 2022–November 2023, in the dietary management of pediatric Crohn's disease.
Test of our hypothesis that exclusive enteral nutrition alleviates Th17 response by eliminating mechanical stress–induced expression of Th17-polarizing cytokines.
The objective of this study was to evaluate the clinical and endoscopic rates of remission after partial enteral nutrition combined with a modified Crohn’s disease exclusion diet adjusted to the local cuisine in comparison with exclusive enteral nutrition for the induction of remission.
Nutrition is an important consideration in the care of children with inflammatory bowel disease to achieve optimal health, correct nutritional deficiencies, achieve weight restoration and maintenance, and complete normative linear growth.
The aim of the study was to outline current understanding of the mechanisms of action of exclusive enteral nutrition in the Crohn's patient.
We assessed alterations in the metabolic profile of newly diagnosed pediatric Crohn’s Disease patients before and during exclusive enteral nutrition therapy.
The aim was to investigate the potential effects of exclusive enteral nutrition on pediatric Crohn's disease activity index, inflammation and biochemical parameters in pediatric patients with Crohn's disease.
The aim was to investigate the potential effects of exclusive enteral nutrition
on pediatric Crohn's disease activity index, inflammation and biochemical parameters in pediatric patients with Crohn's disease.
The survey establishes dietetic practices in implementing exclusive enteral nutrition in the management of active Crohn's disease across specialist pediatric inflammatory bowel disease centers.
This is a study of the adult patient experience with exclusive enteral nutrition, identifying factors to inform clinicians in the development of strategies to help increase patient adherence.